Skip to content

MDMA research published in 2019

Page 4 of 4: studies 61 to 71 of 71, newest first. Back to the MDMA overview

Studies

The Siberian Shaman’s technique of ecstasy

Scripta Instituti Donneriani Aboensis January 16, 2019 Anna-Leena Siikala 21 citations

Changes in the field of observation and body image, attenuated grasp of reality and self-control, which may lead to identification with authority in the case of the shaman with supranormal powers, are all identifying features of shamanic ecstasy. It also appears that some of the basic elements of the shamanic tradition can be explained on the basis of typical marks of identification of altered...

Spirit-possession in theory and practice: séances with Tibetan spirit-mediums in Nepal

Scripta Instituti Donneriani Aboensis January 16, 2019 Per-Arne Berglie

This paper describes a short study of the séances and trance-performances of three Tibetan spirit-mediums (dpa' bo) from a refugee-community in Nepal. The field-work on which this study is based was carried out in a Tibetan refugee-village in Nepal during 1970 and 1971. For each dpa' bo: dBang phyug, Sri gcod, and Nyi ma don grub, a summary of personal thoughts and beliefs concerning possession...

Ecstasy research in the 20th century – an introduction

Scripta Instituti Donneriani Aboensis January 16, 2019 Nils G. Holm 21 citations

Scholars have always been interested in distinctive phenomena in culture and religion. Thus the accounts and achievements of yogis and mystics received attention at an early stage. There is a similar tendency with shamans, different kinds of sorcerers and with the "group-hysterical" phenomena that have appeared from time to time. There is, on the other hand, no major collection of research...

A Case Series of Life-Threatening MDMA Poisoning in An Electronic Dance Music Party in Hong Kong

Asia Pacific Journal of Medical Toxicology January 5, 2019 Francis Chu, Anfernee Yim, Sau Wah Ng 3 citations

Background: MDMA (3,4-methylenedioxymethamphetamine), which is also known as Ecstasy or Molly, is a commonly found abusive agent in Hong Kong. MDMA abuse is widely reported in electronic dance music (EDM) festivals all over the world. It brings about uncommon mortality and serious morbidity with recreational use, which are believed to be related to serotonin toxicity. Cyproheptadine has...

MDMA (ecstasy/molly) use among African Americans: The perceived influence of hip-hop/rap music.

Journal of ethnicity in substance abuse 2019 Khary K. Rigg, Anthony T Estreet

Over the past two decades, the demographic profile of MDMA (ecstasy/molly) users has changed. In particular, African American MDMA use has risen in some cities. One explanation of this new trend is the drug's recent popularity (as molly) in hip-hop/rap (HHR) music. Several top rappers endorse the drug as a way to have fun or get women "loose." There are currently no studies, however, that...

Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City.

Drug and Alcohol Review January 2019 Joseph J Palamar, Monica J Barratt

Ecstasy users in the electronic dance music scene are at high risk for using ecstasy adulterated with new psychoactive substances and/or methamphetamine. We examined self-reported testing of ecstasy among users in this scene. We surveyed individuals (aged 18-40 years) entering electronic dance music parties in New York City in 2017. Past-year ecstasy users (n = 351) were asked if they had...

MDMA-Associated Liver Toxicity: Pathophysiology, Management, and Current State of Knowledge.

AACN advanced critical care 2019 Ruff Joseph Macale Cajanding

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) has become a popular recreational drug of abuse among young adults, partly because of the belief that it is relatively safe compared with other drugs with the same stimulant and hallucinogenic effects. However, MDMA use has been associated with a wide spectrum of organ toxicities, with the liver being severely affected by its deleterious...

DOI: 10.4037/aacnacc2019852 (opens in new tab) Full text (opens in new tab) 4-methylenedioxyamphetamine N-methyl-3 Ecstasy drug Liver failure +4

Ecstasy, Choreography and Re-Enactment: Aesthetic and Political Dimensions of Filming States of Trance and Spirit Possession in Postwar Southern Italy

Visual Anthropology 2019 M. Schäuble 1 citation

States of trance and spirit possession have inspired the modernist imagination perhaps more than anything else, as they typically exceed the limits of visual representation. This article investigates different approaches to coping with these challenges, focusing on the works of a group of Italian documentary filmmakers, including Luigi di Gianni, Cecilia Mangini, and Gianfranco Mingozzi, who...

Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs

Drug Science, Policy and Law 2019 Edward James, Thomas L Robertshaw, Michael J Pascoe et al. 3 citations

Background: Contemporary research indicates that the legal classifications of cannabis (Schedule 2, Class B), 3,4-methylenedioxymethamphetamine (MDMA) (Schedule 1, Class A) and psilocybin (Schedule 1, Class A) in the United Kingdom are not entirely based on considerations of harm and therapeutic utility. The legal classifications of the substances discussed are typically determined by...

Advances in Psychedelic Medicine

2019 17 citations

Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems. More than a decade ago, the U.S. government lifted its ban on all testing of psychedelic substances. Winkelman and Sessa now provide updated scientific research and applications of these substances, now...

Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example.

Journal of Psychoactive Drugs 2019 Anne C Wagner, Michael C Mithoefer, Ann T Mithoefer et al. 92 citations

Treatments for posttraumatic stress disorder (PTSD) have evolved significantly in the past 35 years. From what was historically viewed as a pervasive, intractable condition have emerged multiple evidence-based intervention options. These treatments, predominantly cognitive behavioral in orientation, provide significant symptom improvement in 50-60% of recipients. The treatment of PTSD with...